Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Parkinson's Disease

  Free Subscription


Articles published in Ann Neurol

Retrieve available abstracts of 53 articles:
HTML format
Text format



Single Articles


    January 2018
  1. GRUNTZ K, Bloechliger M, Becker C, Jick SS, et al
    Parkinson's disease and the risk of epileptic seizures.
    Ann Neurol. 2018 Jan 25. doi: 10.1002/ana.25157.
    PubMed     Text format     Abstract available


    November 2017
  2. KAASINEN V, Vahlberg T
    Striatal dopamine in Parkinson's disease: A meta-analysis of imaging studies.
    Ann Neurol. 2017 Nov 22. doi: 10.1002/ana.25103.
    PubMed     Text format     Abstract available


  3. BURY AG, Pyle A, Elson JL, Greaves L, et al
    Mitochondrial DNA changes in pedunculopontine cholinergic neurons in Parkinson's.
    Ann Neurol. 2017 Nov 17. doi: 10.1002/ana.25099.
    PubMed     Text format     Abstract available


    October 2017
  4. LEE Y, Oh JS, Chung SJ, Chung SJ, et al
    Does Smoking Impact Dopamine Neuronal Loss in de novo Parkinson's Disease?
    Ann Neurol. 2017 Oct 23. doi: 10.1002/ana.25082.
    PubMed     Text format    


  5. CAMACHO-SOTO A, Warden MN, Searles Nielsen S, Salter A, et al
    Traumatic Brain Injury in the Prodromal Period of Parkinson Disease: A Large Epidemiological Study Using Medicare Data.
    Ann Neurol. 2017 Oct 10. doi: 10.1002/ana.25074.
    PubMed     Text format     Abstract available


  6. CHUANG YH, Lee PC, Vlaar T, Mulot C, et al
    Pooled analysis of the HLA-DRB1 by smoking interaction in Parkinson's disease.
    Ann Neurol. 2017 Oct 5. doi: 10.1002/ana.25065.
    PubMed     Text format     Abstract available


  7. SCHONHAUT DR, McMillan CT, Spina S, Dickerson BC, et al
    18 F-flortaucipir tau PET distinguishes established progressive supranuclear palsy from controls and Parkinson's disease: A multicenter study.
    Ann Neurol. 2017 Oct 5. doi: 10.1002/ana.25060.
    PubMed     Text format     Abstract available


    September 2017
  8. STORZER L, Butz M, Hirschmann J, Abbasi O, et al
    Bicycling suppresses abnormal beta synchrony in the Parkinsonian basal ganglia.
    Ann Neurol. 2017 Sep 11. doi: 10.1002/ana.25047.
    PubMed     Text format     Abstract available


  9. STRANIERO L, Guella I, Cilia R, Parkkinen L, et al
    DNAJC12 and dopa-responsive non-progressive Parkinsonism.
    Ann Neurol. 2017 Sep 11. doi: 10.1002/ana.25048.
    PubMed     Text format     Abstract available


    August 2017
  10. IRANZO A, Santamaria J, Valldeoriola F, Serradell M, et al
    Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic REM sleep behavior disorder.
    Ann Neurol. 2017 Aug 22. doi: 10.1002/ana.25026.
    PubMed     Text format     Abstract available


    June 2017
  11. HORN A, Reich M, Vorwerk J, Li N, et al
    Connectivity predicts deep brain stimulation outcome in Parkinson's disease.
    Ann Neurol. 2017 Jun 6. doi: 10.1002/ana.24974.
    PubMed     Text format     Abstract available


    May 2017
  12. MUSACCHIO T, Rebenstorff M, Fluri F, Brotchie JM, et al
    STN-DBS is neuroprotective in the A53T alpha-synuclein Parkinson's disease rat model.
    Ann Neurol. 2017 May 3. doi: 10.1002/ana.24947.
    PubMed     Text format     Abstract available


    April 2017
  13. SEIDEL K, Bouzrou M, Heidemann N, Kruger R, et al
    Involvement of the cerebellum in Parkinson's disease and Dementia with Lewy bodies.
    Ann Neurol. 2017 Apr 25. doi: 10.1002/ana.24937.
    PubMed     Text format     Abstract available


    March 2017
  14. CHEN X, Chen H, Cai W, Maguire M, et al
    The melanoma-linked "redhead" MC1R influences dopaminergic neuron survival.
    Ann Neurol. 2017;81:395-406.
    PubMed     Text format     Abstract available


    February 2017
  15. KAUFMANN H, Norcliffe-Kaufmann L, Palma JA, Biaggioni I, et al
    Natural history of pure autonomic failure: A United States prospective cohort.
    Ann Neurol. 2017;81:287-297.
    PubMed     Text format     Abstract available


    January 2017
  16. KORDOWER JH, Goetz CG, Chu Y, Halliday GM, et al
    Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient.
    Ann Neurol. 2017;81:46-57.
    PubMed     Text format     Abstract available


    December 2016
  17. PAGANO G, Niccolini F, Fusar-Poli P, Politis M, et al
    Serotonin transporter in Parkinson's disease: A meta-analysis of PET studies.
    Ann Neurol. 2016 Dec 26. doi: 10.1002/ana.24859.
    PubMed     Text format     Abstract available


  18. BRAKEDAL B, Haugarvoll K, Tzoulis C
    Simvastatin is associated with decreased risk of Parkinson Disease.
    Ann Neurol. 2016 Dec 26. doi: 10.1002/ana.24857.
    PubMed     Text format    


  19. YEN SJ, Lin KD
    Reply to "Simvastatin is associated with decreased risk of Parkinson Disease" by Brage Brakedal.
    Ann Neurol. 2016 Dec 26. doi: 10.1002/ana.24862.
    PubMed     Text format    


    October 2016
  20. LIN KD, Shin SJ
    Reply to 'Risk reduction of Parkinson disease by statin therapy in patients with diabetes' by T. Kawada.
    Ann Neurol. 2016 Oct 31. doi: 10.1002/ana.24813.
    PubMed     Text format    


  21. KAWADA T
    Risk reduction of Parkinson disease by statin therapy in patients with diabetes.
    Ann Neurol. 2016 Oct 27. doi: 10.1002/ana.24809.
    PubMed     Text format    


  22. STANDAERT DG, Geldmacher DS
    GBA, Parkinson disease, and the "senses and intellect".
    Ann Neurol. 2016 Oct 25. doi: 10.1002/ana.24808.
    PubMed     Text format    


  23. INZELBERG R, Flash S, Friedman E, Azizi E, et al
    Cutaneous malignant melanoma and Parkinson's disease: common pathways?
    Ann Neurol. 2016 Oct 19. doi: 10.1002/ana.24802.
    PubMed     Text format     Abstract available


    September 2016
  24. LIU G, Boot B, Locascio JJ, Jansen IE, et al
    Neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's.
    Ann Neurol. 2016 Sep 22. doi: 10.1002/ana.24781.
    PubMed     Text format     Abstract available


  25. CILIA R, Tunesi S, Marotta G, Cereda E, et al
    Survival and dementia in GBA-associated Parkinson Disease: The mutation matters.
    Ann Neurol. 2016 Sep 15. doi: 10.1002/ana.24777.
    PubMed     Text format     Abstract available


    July 2016
  26. LIN KD, Yang CY, Lee MY, Ho SC, et al
    Statin Therapy Prevents the Onset of Parkinson Disease in Patients with Diabetes.
    Ann Neurol. 2016 Jul 29. doi: 10.1002/ana.24751.
    PubMed     Text format     Abstract available


    June 2016
  27. MITROFANIS J, Moro C, Benabid AL
    Further analysis of the neuroprotective effect of near-infrared light in a monkey model of Parkinson disease.
    Ann Neurol. 2016 Jun 4. doi: 10.1002/ana.24696.
    PubMed     Text format    


    April 2016
  28. GUELLA I, Evans DM, Szu-Tu C, Nosova E, et al
    alpha-synuclein genetic variability: A biomarker for dementia in Parkinson's disease.
    Ann Neurol. 2016 Apr 18. doi: 10.1002/ana.24664.
    PubMed     Text format     Abstract available


  29. JIANG T, Zhang YD, Tan L, Yu JT, et al
    DNAJC6 variants in Parkinson's disease and amyotrophic lateral sclerosis.
    Ann Neurol. 2016 Apr 4. doi: 10.1002/ana.24658.
    PubMed     Text format    


    March 2016
  30. STOKHOLM MG, Danielsen EH, Hamilton-Dutoit SJ, Borghammer P, et al
    Pathological alpha-synuclein in gastrointestinal tissues from prodromal parkinson's disease patients.
    Ann Neurol. 2016 Mar 26. doi: 10.1002/ana.24648.
    PubMed     Text format     Abstract available


  31. TELL-MARTI G, Anton Puig-Butille J, Potrony M, Badenas C, et al
    Reply to Letter to Editor ANA-16-0021 'Lack of association between MC1R variants and Parkinson's disease in European descent' by Jiang Q and Liu G.
    Ann Neurol. 2016 Mar 2. doi: 10.1002/ana.24629.
    PubMed     Text format    


  32. JIANG Q, Liu G
    Lack of association between MC1R variants and Parkinson's disease in European descent.
    Ann Neurol. 2016 Mar 2. doi: 10.1002/ana.24627.
    PubMed     Text format    


    December 2015
  33. ELSAYED LE, Drouet V, Usenko T, Mohammed IN, et al
    A novel nonsense mutation in DNAJC6 expands the phenotype of autosomal recessive juvenile-onset Parkinson disease.
    Ann Neurol. 2015 Dec 24. doi: 10.1002/ana.24591.
    PubMed     Text format    


  34. POSTON KL, YorkWilliams S, Zhang K, Cai W, et al
    Compensatory Neural Mechanisms in Cognitively Unimpaired Parkinson's Disease.
    Ann Neurol. 2015 Dec 22. doi: 10.1002/ana.24585.
    PubMed     Text format     Abstract available


  35. LORENZO-BETANCOR O, Wszolek ZK, Ross OA
    Rare variants in MC1R/TUBB3 exon 1 are not associated with Parkinson's disease.
    Ann Neurol. 2015 Dec 17. doi: 10.1002/ana.24581.
    PubMed     Text format    


    November 2015
  36. DONADIO V, Incensi A, Piccinini C, Cortelli P, et al
    Skin nerve misfolded alpha-synuclein in pure autonomic failure and Parkinson disease.
    Ann Neurol. 2015 Nov 25. doi: 10.1002/ana.24567.
    PubMed     Text format     Abstract available


  37. GRUNEWALD A, Rygiel KA, Hepplewhite PD, Morris CM, et al
    Mitochondrial DNA depletion in respiratory chain-deficient Parkinson disease neurons.
    Ann Neurol. 2015 Nov 25. doi: 10.1002/ana.24571.
    PubMed     Text format     Abstract available


  38. OLGIATI S, Quadri M, Fang M, Rood JP, et al
    DNAJC6 mutations associated with early-onset Parkinson's disease.
    Ann Neurol. 2015 Nov 3. doi: 10.1002/ana.24553.
    PubMed     Text format     Abstract available


    October 2015
  39. DARLOT F, Moro C, El Massri N, Chabrol C, et al
    Near-infrared light is neuroprotective in a monkey model of Parkinson's disease.
    Ann Neurol. 2015 Oct 11. doi: 10.1002/ana.24542.
    PubMed     Text format     Abstract available


  40. KAUFMANN H
    Cutting the vagal highway blocks one point of entry for prion-like alpha-synuclein.
    Ann Neurol. 2015;78:520-1.
    PubMed     Text format    


    September 2015
  41. TYSNES OB, Kenborg L, Herlofson K, Steding-Jessen M, et al
    Does vagotomy reduce the risk of Parkinson's disease?
    Ann Neurol. 2015 Sep 29. doi: 10.1002/ana.24531.
    PubMed     Text format    


  42. LUBBE SJ, Escott-Price V, Brice A, Gasser T, et al
    Is the MC1R variant p.R160W associated with Parkinson's?
    Ann Neurol. 2015 Sep 21. doi: 10.1002/ana.24527.
    PubMed     Text format    


  43. TELL-MARTI G, Puig-Butille JA, Potrony M, Badenas C, et al
    Reply to Letter to Editor ANA-15-1051 'Is the MC1R variant p.R160W associated with Parkinson's?' by Lubbe SJ, Escott-Price V, Brice A, et al.
    Ann Neurol. 2015 Sep 21. doi: 10.1002/ana.24526.
    PubMed     Text format    


  44. SVENSSON E, Horvath-Puho E, Thomsen RW, Djurhuus JC, et al
    Does vagotomy reduce the risk of Parkinson's disease - the authors reply.
    Ann Neurol. 2015 Sep 15. doi: 10.1002/ana.24518.
    PubMed     Text format    


  45. PYLE A, Brennan R, Kurzawa-Akanbi M, Yarnall A, et al
    Reduced CSF mitochondrial DNA is a biomarker for early-stage Parkinson's disease.
    Ann Neurol. 2015 Sep 7. doi: 10.1002/ana.24515.
    PubMed     Text format     Abstract available


    August 2015
  46. SWANN NC, de Hemptinne C, Aron AR, Ostrem JL, et al
    Elevated synchrony in Parkinson's disease detected with electroencephalography.
    Ann Neurol. 2015 Aug 20. doi: 10.1002/ana.24507.
    PubMed     Text format     Abstract available


  47. NAZERI A, Roostaei T, Sadaghiani S, Chakravarty MM, et al
    Genome-wide variant by serum urate interaction in Parkinson's Disease.
    Ann Neurol. 2015 Aug 18. doi: 10.1002/ana.24504.
    PubMed     Text format     Abstract available


  48. GRAY MT, Munoz DG, Schlossmacher MG, Gray DA, et al
    Protective effect of vagotomy suggests source organ for Parkinson's disease.
    Ann Neurol. 2015 Aug 12. doi: 10.1002/ana.24501.
    PubMed     Text format    


  49. SVENSSON E, Horvath-Puho E, Thomsen RW, Djurhuus JC, et al
    Re: Protective effect of vagotomy suggests source organ for Parkinson's disease.
    Ann Neurol. 2015 Aug 12. doi: 10.1002/ana.24500.
    PubMed     Text format    


    July 2015
  50. TELL-MARTI G, Puig-Butille JA, Potrony M, Badenas C, et al
    Reply: To PMID 25631192.
    Ann Neurol. 2015;78:153-4.
    PubMed     Text format    


  51. VANDERHORST VG, Samardzic T, Saper CB, Anderson MP, et al
    alpha-Synuclein pathology accumulates in sacral spinal visceral sensory pathways.
    Ann Neurol. 2015;78:142-9.
    PubMed     Text format     Abstract available


    June 2015
  52. WARREN OLANOW C, Bartus RT, Baumann TL, Factor S, et al
    Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial.
    Ann Neurol. 2015 Jun 10. doi: 10.1002/ana.24436.
    PubMed     Text format     Abstract available


    May 2015
  53. SVENSSON E, Horvath-Puho E, Thomsen RW, Djurhuus JC, et al
    Vagotomy and subsequent risk of Parkinson's disease.
    Ann Neurol. 2015 May 29. doi: 10.1002/ana.24448.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: